Yubo International Biotech Ltd (YBGJ)
0.0905
-0.04
(-32.86%)
USD |
OTCM |
Nov 14, 13:05
Yubo International Biotech Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 76.29% |
| December 31, 2023 | 81.05% |
| September 30, 2023 | 80.30% |
| June 30, 2023 | 61.89% |
| March 31, 2023 | 36.84% |
| December 31, 2022 | 43.50% |
| September 30, 2022 | 65.84% |
| June 30, 2022 | 73.41% |
| Date | Value |
|---|---|
| March 31, 2022 | 54.34% |
| December 31, 2021 | 65.87% |
| September 30, 2021 | 74.46% |
| June 30, 2021 | 60.60% |
| March 31, 2021 | 68.26% |
| December 31, 2020 | 91.55% |
| September 30, 2020 | 67.61% |
| June 30, 2020 | 91.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
36.84%
Minimum
Mar 2023
91.59%
Maximum
Jun 2020
68.34%
Average
67.93%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Hologic Inc | 56.45% |
| Nuwellis Inc | 67.18% |
| Linike Medical Group Ltd | -- |
| Varex Imaging Corp | 31.99% |
| Quanterix Corp | 58.03% |